Aquestive Therapeutics (AQST) Inventory (2017 - 2026)

Aquestive Therapeutics' Inventory history runs 10 years deep, the most recent figure standing at $8.1 million for Q1 2026.

• On a quarterly basis, Inventory rose 12.06% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 12.06% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 2.07% from the prior year.
• Inventory advanced to $8.1 million in Q1 2026 per AQST's latest filing, from $6.2 million in the prior quarter.
• Across five years, Inventory topped out at $8.1 million in Q2 2025 and bottomed at $4.6 million in Q1 2022.
• The 5-year median for Inventory is $7.0 million (2024), against an average of $6.7 million.
• Across the five-year window, Inventory soared 134.89% in 2022 and retreated 10.71% in 2024, its largest moves.
• Year by year, Inventory stood at $5.8 million in 2022, then increased by 17.11% to $6.8 million in 2023, then dropped by 10.71% to $6.0 million in 2024, then gained by 2.07% to $6.2 million in 2025, then soared by 30.75% to $8.1 million in 2026.
• Per Business Quant, the three latest AQST Inventory figures stand at $8.1 million (Q1 2026), $6.2 million (Q4 2025), and $7.9 million (Q3 2025).